  Abbreviations, acronyms & symbols   
  ----------------------------------- ---------------------------------------------------------
  AKI                                 = Acute kidney injury
  AMI                                 = Acute myocardial infarction
  BMI                                 = Body mass index
  CABG                                = Coronary artery bypass graft
  CPB                                 = Cardiopulmonary bypass
  EGFR                                = Estimated glomerular filtration rate
  EuroSCORE II                        = European System for Cardiac Operative Risk Evaluation
  ICU                                 = Intensive care unit

INTRODUCTION
============

Acute kidney injury (AKI) is a disease of complex etiology, not fully understood, that often takes place in the postoperative period of cardiovascular surgery^\[[@r1]\]^. The incidence of postoperative AKI in cardiovascular surgery remains high, approximately 20% of such surgical patients are affected^\[[@r2],[@r3]\]^.

In addition to being associated with postoperative complications, longer hospitalizations, risk of infection and greater costs to the health system, AKI is an independent predictor of intra-hospital mortality; since it increases mortality by up to eight times, consequently decreasing the survival of patients^\[[@r3],[@r4]\]^.

Among those undergoing cardiovascular surgery, 1% to 5% may require renal replacement therapy^\[[@r4]\]^. Clinical variables influence the occurrence of postoperative AKI, among other complications, and decreased survival rates^\[[@r1],[@r5],[@r6]\]^. Long-term survival among patients who underwent cardiovascular surgery and acquired postoperative AKI requiring dialysis should be evaluated in a diversified context, since it may confirm information regarding length of survival and its associated risk factors. The aim of this study is to analyze the risk factors in patients who acquired postoperative AKI requiring dialysis after cardiovascular surgery and analyze its survival rates.

METHODS
=======

This retrospective study was conducted in a large public Brazilian hospital specialized in cardiology. Consecutive patients referred to cardiovascular surgery in a 4-year period were analyzed. Patients older than 18 years old, who underwent cardiovascular surgery and presented AKI requiring dialysis up to 30 days in the postoperative period, were eligible. Those who underwent congenital surgeries and cardiac transplantation were excluded.

Data concerning clinical characteristics were analyzed and assigned into three different groups. Preoperative variables were: sex, age, body mass index (BMI), ethnicity, EuroSCORE (European System for Cardiac Operative Risk Evaluation) II, estimated glomerular filtration rate (EGFR) and comorbidities. Intraoperative variables were: type of surgery, cardiopulmonary bypass (CPB) time, use of vasoactive drugs and the use of an intra-aortic balloon pump. Postoperative variables included: length of mechanical ventilation, the use of vasoactive drugs, red blood cells transfusions, clinical complications, length of stay in the intensive care unit (ICU) and death.

Each patient\'s BMI was classified according to the guidelines established by the World Health Organization and were used to assess nutritional status^\[[@r7]\]^. The official website of the EuroSCORE II was used to calculate the patients\' score ([www.euroscore.org](www.euroscore.org)). The Cockcroft-Gault formula was used to estimate the glomerular filtration rate (acute kidney injury stage 1 - increase in serum creatinine of ≥ 0.3 mg/dL or an increase of 50 - 200% from baseline; stage 2 - increase in serum creatinine of 200 - 300%; and stage 3 - increase in serum creatinine of \> 300% or serum creatinine level \> 4 mg/dL). The last laboratory result concerning the preoperative serum creatinine levels was used and patients were classified according to the classification established by the National Kidney Foundation (2005)^\[[@r8]\]^. Survival was verified by consulting their ambulatory follow-up records. When necessary, phone calls were performed.

IBM-SPSS (Statistical Package for the Social Sciences) version 19.0 (SPSS Institute, Chicago, Illinois, USA) was used for the statistical analysis. Fisher\'s exact test was used to compare the categorical variables. The survival of patients was estimated and graphically represented using the Kaplan-Meier curves. The log-rank test was used to compare survival curves. Pairwise comparison was performed when there were more than two groups with Bonferroni correction. Variables that were statistically significant (*P*\<0.1) were submitted to multiple analyses according to the Cox\'s proportional hazards model. Subsequently, the StepWise Backward method was performed to obtain the final model. The variables that presented *P*\<0.05 on the latter were considered significant.

This study was approved by the Institutional Review Board at the hospital where the data were collected (protocol No. 4205/12).

RESULTS
=======

A total of 5,189 cardiovascular surgeries were conducted on adult patients on the period of the study and 157 patients were identified in accordance with the eligibility criteria. The patients\' characteristics are presented in [Table 1](#t1){ref-type="table"}.

###### 

Clinical characterization and pre, intra and postoperative variables of patients who presented postoperative acute kidney injury after cardiovascular surgery and required dialysis. São Paulo, Brazil 2014.

  -------------------------------------------------------------------------------------------------------------------------------------
                                          Characteristics of patients   N               \%                Mean/SD         Min/Max   
  --------------------------------------- ----------------------------- --------------- ----------------- --------------- --------- ---
  Preoperative variables                  Sex                           Male            92                59                         

  Female                                  65                            41                                                          

  Age (years)                             Older than 60 years of age    86              54.8                                        

  Younger than 60 years of age            71                            45.2                                                        

  BMI                                     Below normal (\<18.5)         7               4.7                                         

  Normal (18.5-24.9)                      49                            32.9                                                        

  Overweight (25.0-29.9)                  49                            32.9                                                        

  Obese class I (30.0-34.9)               30                            20.1                                                        

  Obese class II (35.0-39.9)              10                            6.7                                                         

  Obese class III (≥ 40.0)                4                             2.7                                                         

  Ethnicity                               Caucasian                     123             78.34                                       

  Mixed                                   18                            11.46                                                       

  Afro-descendent                         13                            8.28                                                        

  Asian                                   3                             1.91                                                        

  Comorbidities                           Hypertension                  133             85                                          

  Dyslipidemia                            97                            62                                                          

  Diabetes mellitus                       63                            40                                                          

  Smoking                                 46                            30                                                          

  Prior cardiovascular surgery            41                            27                                                          

  Chronic atrial fibrillation             37                            24                                                          

  Acute myocardial infarction             28                            15                                                          

  Stroke                                  19                            11                                                          

  Chronic obstructive pulmonary disease   9                             6                                                           

  Peripheral vascular disease             2                             1                                                           

                                          EuroSCORE II                  Median: 3.8%\   Quartile range\   Min: 0.75%\               
                                                                        Mean: 6.62%\    2.08% - 7.37%      Max: 52.51%              
                                                                        SD: 7.97%                                                   

  Renal Disease Classification            GFR I - Normal                17              11                                          

  GFR II - Mild                           46                            29                                                          

  GFR III - Moderate                      51                            33                                                          

  GFR IV - Severe                         8                             5                                                           

  GFR V - Renal failure                   35                            22                                                          

  Intraoperative variables                Type of Surgery               VR              78                49.7                       

  Myocardial revascularization            56                            35.7                                                        

  Combined                                20                            12.7                                                        

  Thoracic aortic aneurysm repair         3                             1.9                                                         

  CPB time                                \<120 min                     82              52.2              Mean: 121.45\             
                                                                                                          SD: 58.13                 

  ≥120 min                                75                            47.8                                                        

  Vasoactive drugs                        135                           86.0                                                        

  Intra-aortic balloon                    7                             4.5                                                         

                                          Complications                 Infections      113               72.0                       

  Atrial fibrillation                     71                            45.2                                                        

  Bronchopneumonia                        69                            43.9                                                        

  Cardiorespiratory arrest                33                            21.0                                                        

  Surgical wound infection                30                            19.1                                                        

  Neurological                            19                            11.0                                                        

  Low cardiac output                      18                            11.5                                                        

  Reoperation (hemostasis review)         17                            10.8                                                        

  Gastrointestinal (upper GI bleed)       16                            10.2                                                        

  Others                                  34                            21.7                                                        

  Transfusion of packed red blood cells   83                            52.9                                                        

  Vasoactive drugs                        151                           96.2                                                        

  Length of\                              1-3                           36              23.4                                        
  ICU stay (days)                                                                                                                   

  4-10                                    38                            24.7                                                        

  11-30                                   50                            32.5                                                        

  \>30                                    30                            19.5                                                        

  Time of mechanical ventilation (days)                                                   Mean: 8.3\      Min:0\                    
                                                                                        SD: 15.2          Max: 121.0                
  -------------------------------------------------------------------------------------------------------------------------------------

AMI=acute myocardial infarction; BMI=body mass index; CPB=cardiopulmonary bypass; GFR=glomerular filtration rate; SD=standard deviation; Min=minimum; Max=Maximum; VR=valve replacement

[Table 1](#t1){ref-type="table"} shows a predominance of male patients (59%), aged over 60 years (54.8%), Caucasians (78.34%), and overweight (mean BMI of 27.81 kg/m^2^). Comorbidities included: hypertension (85%), dyslipidemia (62%), diabetes mellitus (40%), smoking (30%), previous cardiac surgery (27%). The mean obtained for the EuroSCORE II was 6.62%.

In regard to the classification of kidney disease in the preoperative, 33% presented GFR III (moderate), 29% GFR II (mild) and 22% GFR V (renal failure). In regard to the type of surgery, valve surgeries (49.7%) predominated, followed by myocardial revascularization (35.7%). The average duration of extracorporeal circulation was 121.45 minutes.

Complications identified in the postoperative period were: infections (72%), atrial fibrillation (45.2%), cardiorespiratory arrest (21%), and other less frequent complications (21.7%) that included acute myocardial infarction (AMI), pleural effusion, cardiac arrhythmias, acute arterial occlusion, mesenteric ischemia and liver failure. Survival was estimated at five different points in time over the follow-up period, considering the variables in the pre, intra and postoperative groups, shown in [Table 2](#t2){ref-type="table"}.

###### 

Association between the pre, intra and postoperative and survival at different points in time with survival and CI 95% (lower lim - upper lim). São Paulo, Brazil 2014.

  ---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
                                                            Time since surgery             30 days        180 days       1 year        2 years       3 and 4 years   *P*-value^[a](#TFN3){ref-type="table-fn"}^
  --------------------------------------------------------- ------------------------------ -------------- -------------- ------------- ------------- --------------- --------------------------------------------
                                                            Overall survival               62.8%\         36.2%\         32.1%\        29.9%\        27.6%\           
                                                                                           (55.3-70.4)    (28.7-43.8)    (24.7-39.5)   (22.6-37.2)   (20.2-35.0)     

  **Preoperative**                                                                                                                                                   

  Age                                                       \<60 years old                 78.6%\         46.5%\         43.2%\        41.5%\        38.8%\          0.001
                                                                                           (69.0-88.2)    (34.7-58.3)    (31.4-55.0)   (29.8-53.3)   (26.6-51.0)     

  \>60 years old                                            50.0%\                         27.9%\         23.3%\         20.9%\        19.0%\                        
                                                            (39.4-60.6)                    (18.4-37.4)    (14.3-32.2)    (12.3-29.5)   (10.4-27.6)                   

  Sex                                                       Female                         67.7%\         30.7%\         29%\          27.3%\        27.3%\          0.933
                                                                                           (56.3-79.1)    (19.5-41.9)    (17.9-40.1)   (16.3-38.2)   (16.3-38.2)     

  Male                                                      59.4%\                         40.3%\         34.4%\         31.7%\        27.6%\                        
                                                            (49.3-69.5)                    (30.2-50.5)    (24.5-44.3)    (21.9-41.5)   (17.5-37.7)                   

  Comorbidities                                             Diabetes mellitus              72.8%\         38.8%\         28.2%\        28.2%\        25.1%\          0.642
                                                                                           (61.8-83.9)    (26.6-50.9)    (16.8-39.6)   (16.8-39.6)   (13.4-36.7)     

  Hypertension                                              64.4%\                         39.1%\         34.1%\         31.5%\        28.5%\        0.26            
                                                            (56.3-72.6)                    (30.7-47.4)    (25.9-42.3)    (23.4-39.6)   (20.2-36.8)                   

  Dyslipidemia                                              65.7%\                         40.1%\         34.4%\         31.9%\        27.8%\        0.373           
                                                            (56.2-75.2)                    (30.3-50.0)    (24.7-44.1)    (22.3-41.5)   (17.8-37.7)                   

  Prior AMI                                                 73.4%\                         45.4%\         40.4%\         35.3%\        23.6%\        0.477           
                                                            (55.2-91.7)                    (24.4-66.4)    (19.5-61.3)    (14.9-55.8)   (0.3-46.8)                    

  BMI                                                       \<25                           65.5%\         40.0%\         35.8%\        33.4%\        30.6%\          0.834
                                                                                           (52.9-78.0)    (27.1-52.9)    (23.0-48.6)   (20.6-46.2)   (17.8-43.5)     

  25-29.9                                                   64.7%\                         34.4%\         32.1%\         29.8%\        29.8%\                        
                                                            (51.1-78.2)                    (20.7-48.0)    (18.6-45.5)    (16.6-43.0)   (16.6-43.0)                   

  ≥30                                                       62.2%\                         35.6%\         28.9%\         26.7%\        21.3%\                        
                                                            (48.1-76.4)                    (21.6-49.5)    (15.6-42.1)    (13.7-39.6)   (7.4-35.3)                    

  GFR                                                       GFR I -- Normal                63.7%\         25.5%\         19.1%\        19.1%\        19.1%\          0.017
                                                                                           (40.4-87.0)    (4.0-47.0)     (0.0-38.5)    (0.0-38.5)    (0.0-38.5)      

  GFR II - Mild                                             53.3%\                         31.1%\         28.7%\         26.3%\        26.3%\                        
                                                            (38.8-67.9)                    (17.6-44.6)    (15.4-42.0)    (13.4-39.3)   (13.4-39.3)                   

  GFR III - Moderate                                        60.0%\                         34.0%\         28.0%\         25.8%\        23.0%\                        
                                                            (46.4-73.6)                    (20.9-47.1)    (15.6-40.4)    (13.7-38.0)   (10.9-35.0)                   

  GFR IV -- Severe^[b](#TFN4){ref-type="table-fn"}^         50.0%\                         12.5%\         12.5%\         12.5%\        12.5%\                        
                                                            (15.4-84.6)                    (0.0-35.4)     (0.0-35.4)     (0.0-35.4)    (0.0-35.4)                    

  GFR V - Kidney failure^[b](#TFN4){ref-type="table-fn"}^   81.8%\                         59.8%\         56.1%\         52.3%\        46.5%\                        
                                                            (68.7-95.0)                    (42.8-76.7)    (38.7-73.4)    (34.6-70.0)   (27.4-65.6)                   

  Intraoperative                                                                                                                                                     

  Type of surgery                                           Myocardial revascularization   71.4%\         44.6%\         35.3%\        33.4%\        27.0%\          0.171
                                                                                           (59.6-83.3)    (31.5-57.6)    (22.7-47.9)   (21.0-45.9)   (14.1-39.9)     

  Valve                                                     57.2%\                         34.6%\         33.1%\         31.6%\        31.6%\                        
                                                            (46.2-68.3)                    (23.8-45.3)    (22.4-43.7)    (21.0-42.1)   (21.0-42.1)                   

  Correction aorta aneurysm                                 100.0%\                        66.7%\         66.7%\         33.3%\        33.3%\                        
                                                            (29.0-100)                     (13.3-100.0)   (13.3-100.0)   (0-86.7)      (0-86.7)                      

  Combined                                                  55.0%\                         15.0%\         15.0%\         15.0%\        15.0%\                        
                                                            (33.2-76.8)                    (0.0-30.6)     (0.0-30.6)     (0.0-30.6)    (0.0-30.6)                    

  CPB time                                                  \< 120min                      63.4%\         46.3%\         41.1%\        37.0%\        34.9%\          0.054
                                                                                           (53.0-73.8)    (35.3-57.1)    (30.4-51.8)   (26.3-47.6)   (24.1-45.7)     

  ≥ 120min                                                  62.1%\                         24.7%\         21.8%\         21.8%\        19.4%\                        
                                                            (51.0-73.2)                    (14.8-34.7)    (12.2-31.4)    (12.2-31.4)   (9.8-29.0)                    

  Vasoactive drugs                                          62.7%\                         34.7%\         31.4%\         29.8%\        26.8%\        0.519           
                                                            (54.5-70.9)                    (26.6-42.8)    (23.5-39.4)    (21.9-37.6)   (18.8-34.9)                   

  Postoperative                                                                                                                                                      

                                                            Vasoactive drugs               63.4%\         35.7%\         31.3%\        29.0%\        26.6%\          0.25
                                                                                           (55.6-71.1)    (28.0-43.4)    (23.8-38.8)   (21.6-36.4)   (19.2-34.1)     

                                                            Blood transfusion              57.6%\         30.6%\         29.4%\        25.6%\        23.8%\          0.16
                                                                                           (47.0-68.3)    (20.7-40.6)    (19.5-39.3)   (16.0-35.1)   (14.4-33.3)     

                                                            Low cardiac output             61.1%\         24.4%\         24.4%\        24.4%\        24.4%\          0.53
                                                                                           (38.6-83.6)    (3.8-45.1)     (3.8-45.1)    (3.8-45.1)    (3.8-45.1)      

  No. of complications                                      0                              88.5%\         82.6%\         62.4%\        62.4%\        41.6%\          0.0003
                                                                                           (73.6-100.0)   (64.8-100.0)   (38.3-86.5)   (38.3-86.5)   (4.6-78.6)      

  1                                                         71.4%\                         51.4%\         48.2%\         41.8%\        41.8%\                        
                                                            (56.5-86.4)                    (34.9-68.0)    (31.5-64.9)    (25.1-58.5)   (25.1-58.5)                   

  2 or more                                                 55.6%\                         23.4%\         21.5%\         20.5%\        15.3%\                        
                                                            (46.0-65.2)                    (15.2-31.6)    (13.5-29.4)    (12.7-28.3)   (6.2-24.4)                    

  Length of stay in ICU (Days)                              1-3                            66.7%\         44.4%\         41.0%\        34.2%\        29.3%\           
                                                                                           (51.3-82.1)    (28.2-60.7)    (24.7-57.3)   (18.1-50.3)   (12.9-45.7)     

  4-10                                                      63.2%\                         44.7%\         36.8%\         36.8%\        36.8%\                        
                                                            (47.8-78.5)                    (28.9-60.5)    (21.5-52.2)    (21.5-52.2)   (21.5-52.2)                   

  11-30                                                     34.0%\                         21.2%\         21.2%\         21.2%\        21.2%\        0.088           
                                                            (20.5-47.4)                    (9.6-32.9)     (9.6-32.9)     (9.6-32.9)    (9.6-32.9)                    

  \>30                                                      100.0%\                        33.0%\         29.3%\         25.1%\        20.1%\                        
                                                            (88.4-100.0)                   (16.0-50.0)    (12.8-45.9)    (9.1-41.2)    (4.5-35.7)                    
  ---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

AMI=acute myocardial infarction; BMI=body mass index; GFR=glomerular filtration rate

Long-rank test;

*P*\<0.05 pairwise with Bonferroni correct. Value are n (%)

[Table 2](#t2){ref-type="table"} shows associations between the pre, intra and postoperative variables and survival rates at different points in time. Overall survival for the first 30 days postoperative was 62.8%. Association between survival and preoperative variables revealed age with *P*-value=0.001; survival rate was lower for patients older than 60 years of age and remained low over time among the patients in this age range.

GFR presented *P*-value=0.017, while patients with GFR V (kidney failure) presented better survival results (81.8%) within 30 days and over time, when compared to the survival of the remaining patients at different stages of kidney disease (GFR I, GFR II, GFR III, GFR IV).

CPB duration was not statistically significant for survival, while the presence of complications was significant (*P*-value=0.0003) in the association between survival and postoperative variables.

Cox regression was performed based on the multivariate analysis and the effect of the covariates age, GFR, CPB time, postoperative complications, length of stay in ICU and survival time was estimated. Data are presented in [Table 3](#t3){ref-type="table"}.

###### 

Analysis of survival among the variables age, GFR, CPB time, complications and length of stay in ICU (Days). São Paulo, Brazil 2014.

  Variables                     HR      CI (95%) of HR   *P*-value   
  ----------------------------- ------- ---------------- ----------- --------
  Age                           1.039   1.019            1.059       0.0001
  GFR I                         1.000                                 
  GFR II                        0.879   0.421            1.835       0.7323
  GFR III                       0.851   0.393            1.839       0.6817
  GFR IV                        1.163   0.404            3.344       0.7785
  GFR V                         0.614   0.252            1.496       0.2833
  CPB time                      1.418   0.924            2.175       0.1095
  Complications                 2.076   1.189            3.623       0.0101
  Length of stay in ICU 1-3     1.000                                 
  Length of stay in ICU 4-10    0.736   0.400            1.356       0.3270
  Length of stay in ICU 11-30   0.871   0.492            1.540       0.6356
  Length of stay in ICU \>30    0.381   0.199            0.733       0.0038

CPB=cardiopulmonary bypass; GFR=glomerular filtration rate; HR=hazard ratio; ICU=intensive care unit

The analysis of significant variables regarding survival showed that the older the patient, the greater the risk of death; the risk increased 3.8% per year of life. For CPB time \>120 min the risk of death increased approximately 1.6 times when compared to patients with CPB time \< 120 min. For patients who presented two or more complications, the risk of death increased approximately 2.3 times when compared to patients with only one complication or no complications. For patients who presented length of stay in ICU \> 30 days, decreased 57% the risk of death when compared to patients with length of stay in ICU \< 3 days. Data are presented in [Table 4](#t4){ref-type="table"}.

###### 

Analysis of survival after stepwise backward: variables age, CPB time, complications and length of stay in ICU. São Paulo, Brazil 2014.

  Variables                     HR      CI (95%) of HR   *P*-value   
  ----------------------------- ------- ---------------- ----------- --------
  Age                           1.037   1.019            1.056       0.0000
  CPB time                      1.600   1.055            2.426       0.0268
  Complications (\>2)           2.300   1.399            3.780       0.0010
  Length of stay in ICU 1-3     1.000                                 
  Length of stay in ICU 4-10    0.776   0.435            1.383       0.3909
  Length of stay in ICU 11-30   0.879   0.502            1.540       0.6536
  Length of stay in ICU 11-30   0.426   0.227            0.8011      0.0081

CPB=cardiopulmonary bypass; HR=hazard ratio; ICU=intensive care unit

[Figure 1](#f1){ref-type="fig"} represents the patients\' overall survival curve. The average time of survival in this study population was 1.5 years, approximately 546 days.

Fig. 1Study patients\' overall survival.

[Figures 2](#f2){ref-type="fig"} and [3](#f3){ref-type="fig"} show survival in regard to the variables age and complications. The dashed line in the first graphic represents only the survival of patients more than the 60 years of age. The first and second dashed lines in the second graphic represent the group with only one complication and two or more complications, respectively.

Fig. 2Relationship between the survival and age of patients.

Fig. 3Relationship between the survival of patients and number of complications.

DISCUSSION
==========

AKI is a complication that frequently affects patients after cardiovascular surgery and is associated with increased mortality^\[[@r9]\]^. The aim of this study is to analyze the risk factors in patients who acquired postoperative AKI requiring dialysis after cardiovascular surgery and analyze its survival rates.

The incidence and adverse outcomes associated with AKI in a population who underwent cardiovascular surgery (myocardial revascularization and valve surgery) from 1999 to 2008 reports that the rates of AKI and AKI requiring dialysis after cardiovascular surgery with extracorporeal circulation relates to age, gender, although controversial^\[[@r10]\]^; type of surgery, heart failure, diabetes mellitus, hypertension, lung disease, peripheral vascular disease, cerebrovascular disease, obesity, sepsis, CPB time, and mechanical ventilation^\[[@r11]\]^.

Advanced age, as observed in this study, has been related to dialytic kidney failure since the kidneys are prone to aging process^\[[@r12]\]^. One analysis with 145,911 patients^\[[@r13]\]^ aged 65 years old or older who had their aortic valve replaced or repaired concomitantly with a myocardial revascularization, between 1991 and 2007, reports an average survival of 13 years for patients aged between 65 and 69 years old, 9 years for those between 70 and 79 and 6 years for patients aged 80 years old or older. Although the type of surgery appears as an important factor associated with decreased survival, it was not significant in this study.

Interestingly, we did not notice in this series relation between BMI and EuroSCORE II to decreased survival since they are well established to dialytic AKI in cardiovascular patients^\[[@r14]-[@r17]\]^. Other factors predicting AKI were identified in patients who had undergone cardiovascular surgery and developed AKI that required dialysis, such as having a preoperative severe status and preexisting kidney disease^\[[@r18]\]^.

Despite the reported survival rate in the first 30 days after surgery, it gradually decreased in subsequent months. Similar evidence was identified in patients with mild preoperative kidney failure, who presented a higher mortality rate in the long term compared to patients whose preoperative kidney function was normal^\[[@r17]\]^.

It is believed that mild and severe preoperative kidney failure leads to a greater incidence of adverse events in the postoperative period^\[[@r19],[@r20]\]^. In this study, preoperative kidney failure requiring dialysis was not related to higher mortality rates. The patients with preoperative kidney failure (GFR V) presented greater postoperative survival in the first 30 days and over time when compared to the remaining patients, which may be associated with early dialysis therapy on the post-operative period.

Patients undergoing dialysis in whom myocardial revascularization was performed present higher mortality, approximately 7% to 10%, which is three times greater than non-uremic patients^\[[@r20]\]^. Long-term results show that the survival of patients undergoing dialysis after coronary artery bypass graft (CABG) is decreased, with mortality in 5 years estimated to be 48%^\[[@r6],[@r11],[@r21]\]^.

Patients who developed some degree of AKI, in addition to presenting high mortality rates, also presented a high risk score, required more blood transfusions^\[[@r6],[@r20]-[@r23]\]^, presented a higher incidence of neurological events, required mechanical ventilation for longer periods, and, consequently, were hospitalized for longer periods with high rates of surgical wound infection^\[[@r20]\]^.

Complications emerging in the preoperative phase of cardiovascular surgeries among patients with AKI requiring dialysis significantly increase mortality rates^\[[@r17],[@r19]\]^. Among potential complications, pulmonary atelectasis is reported as the main complication found in 54% to 92% of patients in the postoperative period of cardiovascular surgery^\[[@r24]\]^. The presence of complications identified in individuals who developed postoperative AKI that requires dialysis after a cardiovascular surgery shows that these patients may require mechanical ventilation for longer periods. On the other hand, mechanical ventilation increases the risk of pulmonary infection, while AKI creates an altered inflammatory environment that may cause atrial arrhythmias^\[[@r6]\]^.

One recent study revealed that AKI stage 1 and stages 2 or 3, according to AKIN criteria, were associated with significant increase, from 31% to 98% of readmission in five years, in addition to significant higher mortality risk, from 1.5 to 3.5 times, five years after surgery^\[[@r25]\]^. Similar results were found in association with increased intra-hospital mortality among patients who initiated dialysis later on (\>3 days) after cardiovascular surgery, in comparison to those who started dialysis within three days after surgery^\[[@r9]\]^.

In this study, 140 out of the 157 patients presented some degree of preoperative kidney disease and only 17 presented normal kidney function. All the patients, however, required postoperative dialysis. Univariate analysis revealed significant differences between the groups GFR IV (severe) and GFR V (renal failure) in the pairwise analysis, with P=0.0109, though the GFR was not significant in the survival of these patients, according to the Cox regression model. It is possible that the fact that preoperative dialysis patients were introduced earlier to dialysis than those who developed postoperative AKI and later required it explains the greater survival rate among the first group of patients. Patients in a previous dialysis program were not related to have long term mortality than new demanding dialysis patients after cardiovascular surgery.

CONCLUSION
==========

Data show an average survival of 546 days among dialytic AKI patients after cardiovascular surgery, while factors such as age, and postoperative complications were determinant regarding decreases in the survival of these patients.

The multidisciplinary staff in the intensive care unit must be aware of the profile of these patients and understands how their clinical condition develops to refer them to early dialysis in order to properly handle AKI and decrease irreversible damage. The planning of interventions in the perioperative period is essential to decreasing the emergence of AKI and avoiding complications, significantly contributing to decreased mortality and improved survival of patients.
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